Patents Assigned to Angiomedics II, Inc.
  • Patent number: 5607419
    Abstract: Disclosed is an apparatus for use in applying UV light to a blood vessel wall following the performance of a balloon angioplasty procedure. It comprises an elongated optical fiber whose outside diameter permits it to be inserted into the lumen of a guidewire that is used to position the angioplasty balloon at the site of the lesion to be treated. The guidewire is provided with a light port and a suitable reflector is provided for causing UV light transmitted through the optical fiber to be radiated in a radial direction through the light port in the guidewire to thereby irradiate the vessel wall with UV energy that has been found effective in retarding growth of smooth muscle cells.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: March 4, 1997
    Assignee: AngioMedics II Inc.
    Inventors: Curtis A. Amplatz, James S. Sharrow
  • Patent number: 5246004
    Abstract: Systems and methods for non-invasive blood analysis are disclosed in which blood is illuminated at a plurality of discrete wavelengths selected from the near infrared spectrum. Measurements of the intensity of reflected or transmitted light at such wavelengths are taken, and an analysis of reflectance or transmittance ratios for various wavelengths is performed. Changes in the ratios can be correlated with specific material properties, such as the concentration of cholesterol in a subject's circulatory system.
    Type: Grant
    Filed: August 14, 1992
    Date of Patent: September 21, 1993
    Assignee: Angiomedics II, Inc.
    Inventors: Richard H. Clarke, Qian Wang
  • Patent number: 5222496
    Abstract: Systems and methods for non-invasive blood analysis for the presence of glucose are disclosed in which blood is illuminated at a plurality of discrete wavelengths selected from the near infrared spectrum. Measurements of the intensity of transmitted or reflected light at such wavelengths are taken, and an analysis of transmittance or reflectance ratios for various wavelengths is performed. Changes in the ratios can be correlated with specific near infrared (IR) absorption peak for glucose at about 1600 nm +/-15 nm which varies with concentration of the analyte (the data wavelength) and the a second (reference) wavelength being sufficiently removed from the first so that measurements of light absorption at this second wavelength are relatively insensitive to the concentration of the analyte and yet the second wavelength is sufficiently close to the first wavelength to minimize interference from scattering effects and the like.
    Type: Grant
    Filed: August 14, 1992
    Date of Patent: June 29, 1993
    Assignee: Angiomedics II, Inc.
    Inventors: Richard H. Clarke, Qian Wang
  • Patent number: 5222495
    Abstract: Systems and methods for non-invasive blood analysis are disclosed in which blood is illuminated at a plurality of discrete wavelengths selected from the near infrared spectrum. Measurements of the intensity of transmitted or reflected light at such wavelengths are taken, and an analysis of transmittance or reflectance ratios for various wavelengths is performed. Changes in the ratios can be correlated with specific near infrared (IR) absorption peak for the analyte which varies with concentration of the analyte (the data wavelength) and the a second (reference) wavelength being sufficiently removed from the first so that measurements of light absorption at this second wavelength are relatively insensitive to the concentration of the analyte and yet the second wavelength is sufficiently close to the first wavelength to minimize interference from scattering effects and the like.
    Type: Grant
    Filed: August 14, 1992
    Date of Patent: June 29, 1993
    Assignee: Angiomedics II, Inc.
    Inventors: Richard H. Clarke, Qian Wang